News

FDA approves powerful HIV drug with the potential to end the epidemic in the U.S.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
FDA approves powerful new HIV drug
The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s ...
FDA announces sweeping changes to speed up the drug review process
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...
FDA offers speedier approvals to drug companies aligning with 'national priorities'
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
New FDA Chief Wants to Fast-Track Some Drugs, Use More AI
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
FDA to offer faster drug reviews to companies promoting ‘national priorities’
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
STAT6h
Vinay Prasad named chief medical and science officer at FDA
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
STAT23h
FDA announces a new priority review program in bid to further administration goals
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
MIT Technology Review5d
Here’s what food and drug regulation might look like under the Trump administration
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...